MHR restructures Telesat stake through a continuation vehicle, granting the lead investor a board seat and liquidity rights

summarizeSummary

MHR restructured its 35.4% Telesat stake through a continuation vehicle backed by RenWave Kore, granting the new investor a board seat and contractual liquidity rights that could force share sales if return thresholds aren't met within five years.

check_boxKey Events · Ownership and Investor Activity · TSAT

• MHR Completes Continuation Vehicle Restructuring

  On July 8, 2026, MHR Fund Management and affiliates closed a CV Transaction, transferring Telesat Class B Units from legacy funds to new entities (SAT Holdco A/B, SAT SubHoldco A/B) backed by RenWave Kore and MHR Sun Holdings. Dr. Rachesky and MHR retain control; aggregate beneficial ownership reported at 35.5% and 35.4%, respectively.

• Lead Investor Gains Board Designation Right

  Under a Side Letter, MHR must use its board designation rights to appoint one individual identified by the Lead Investor (Cody Kittle pre-approved) to Telesat's board, subject to governance processes. This gives the new capital partner direct influence over company strategy.

• Minimum Liquidity Threshold Creates Forced Sale Risk

  If the Lead Investor has not received distributions equal to 125% of its capital contributions by the fifth anniversary plus three months, it can force SAT SubHoldco A and B to transfer Telesat shares to meet the shortfall. This hardwired liquidity right could pressure the stock if returns lag.

• Wind Down Right Adds Long-Term Overhang

  At the seven-year term expiration plus six months, if material Telesat assets remain, the Lead Investor can require a qualified liquidation or distribution in kind. If MHR obstructs, the Lead Investor can directly transfer shares to itself, creating a potential future supply overhang.

auto_awesomeAnalysis · TSAT · Technology

Telesat's largest shareholder, MHR Fund Management, has completed a continuation vehicle transaction that reshuffles its 35.4% stake into new entities backed by outside capital from RenWave Kore. The deal gives the new lead investor a board seat (Cody Kittle) and hardwired liquidity rights: if 125% of its capital isn't returned within roughly five years, it can force share sales. A wind-down mechanism after seven years adds further pressure. This isn't a sale—control stays with Dr. Rachesky—but the structure introduces a clock on monetization and a new voice in the boardroom, both material for a company navigating a 25% revenue decline and a critical military contract win.